CN Patent

CN106146501A — 一种无定型激酶抑制剂的制备方法

Assigned to Jiangsu Hansoh Pharmaceutical Group Co Ltd · Expires 2016-11-23 · 9y expired

What this patent protects

本发明涉及一种无定型激酶抑制剂的制备方法，包括：将Idelalisib溶解在良性溶剂中，接着将其滴入不良溶剂，搅拌析晶，得Idelalisib无定型。该方法操作便捷。

USPTO Abstract

本发明涉及一种无定型激酶抑制剂的制备方法，包括：将Idelalisib溶解在良性溶剂中，接着将其滴入不良溶剂，搅拌析晶，得Idelalisib无定型。该方法操作便捷。

Drugs covered by this patent

Patent Metadata

Patent number: CN106146501A
Jurisdiction: CN
Classification: —
Expires: 2016-11-23
Drug substance claim: No
Drug product claim: No
Assignee: Jiangsu Hansoh Pharmaceutical Group Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.